Search research articles
Contact Us
Filters
Showing results (71-80 of 85) with videos related to
Page
of 9
Sort By:
Transplantation and Cellular Therapy
|
June 16, 2026
Allogeneic Transplantation in the rare disease MDS/MPN with Neutrophilia: Age and Disease Burden Determine Outcome
Annemarie Mohring, Katja Sockel, Christian Thiede, et al.
Journal for Immunotherapy of Cancer
|
November 25, 2020
Regorafenib combined with PD1 blockade increases CD8 T-cell infiltration by inducing CXCL10 expression in hepatocellular carcinoma
Kohei Shigeta, Aya Matsui, Hiroto Kikuchi, et al.
NPJ Digital Medicine
|
August 19, 2023
Predicting HPV association using deep learning and regular H&E stains allows granular stratification of oropharyngeal cancer patients
Sebastian Klein, Nora Wuerdemann, Imke Demers, et al.
Gut
|
April 15, 2026
CD16<sup>+</sup> γδ T cells mediate antibody-dependent cellular cytotoxicity and associate with viral control in chronic hepatitis B virus infection
Paulina E Schröter, Katja Steppich, Laura Fernández Carrera, et al.
NPJ Precision Oncology
|
June 17, 2021
Cancer-specific immune evasion and substantial heterogeneity within cancer types provide evidence for personalized immunotherapy
Martin Thelen, Kerstin Wennhold, Jonas Lehmann, et al.
Nature Communications
|
August 4, 2019
MYC paralog-dependent apoptotic priming orchestrates a spectrum of vulnerabilities in small cell lung cancer
Marcel A Dammert, Johannes Brägelmann, Rachelle R Olsen, et al.
Blood
|
April 23, 2026
Expression of cFLIP in B cells is essential for diffuse large B-cell lymphoma pathogenesis
Kristie Tanavura Bariboloka, Santiago Serrano-Saenz, Deniz Pinar Savcigil, et al.
Gut
|
January 12, 2021
Placental growth factor promotes tumour desmoplasia and treatment resistance in intrahepatic cholangiocarcinoma
Shuichi Aoki, Koetsu Inoue, Sebastian Klein, et al.
Blood Cancer Discovery
|
November 8, 2022
Distinct Genetically Determined Origins of Myd88/BCL2-Driven Aggressive Lymphoma Rationalize Targeted Therapeutic Intervention Strategies
Ruth Flümann, Julia Hansen, Benedikt W Pelzer, et al.
Blood Cancer Discovery
|
January 15, 2021
An Autochthonous Mouse Model of Myd88- and BCL2-Driven Diffuse Large B-cell Lymphoma Reveals Actionable Molecular Vulnerabilities
Ruth Flümann, Tim Rehkämper, Pascal Nieper, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 85) with videos related to
Sort By:
Page
of 9
Transplantation and Cellular Therapy
|
June 16, 2026
Allogeneic Transplantation in the rare disease MDS/MPN with Neutrophilia: Age and Disease Burden Determine Outcome
Annemarie Mohring, Katja Sockel, Christian Thiede, et al.
Journal for Immunotherapy of Cancer
|
November 25, 2020
Regorafenib combined with PD1 blockade increases CD8 T-cell infiltration by inducing CXCL10 expression in hepatocellular carcinoma
Kohei Shigeta, Aya Matsui, Hiroto Kikuchi, et al.
NPJ Digital Medicine
|
August 19, 2023
Predicting HPV association using deep learning and regular H&E stains allows granular stratification of oropharyngeal cancer patients
Sebastian Klein, Nora Wuerdemann, Imke Demers, et al.
Gut
|
April 15, 2026
CD16<sup>+</sup> γδ T cells mediate antibody-dependent cellular cytotoxicity and associate with viral control in chronic hepatitis B virus infection
Paulina E Schröter, Katja Steppich, Laura Fernández Carrera, et al.
NPJ Precision Oncology
|
June 17, 2021
Cancer-specific immune evasion and substantial heterogeneity within cancer types provide evidence for personalized immunotherapy
Martin Thelen, Kerstin Wennhold, Jonas Lehmann, et al.
Nature Communications
|
August 4, 2019
MYC paralog-dependent apoptotic priming orchestrates a spectrum of vulnerabilities in small cell lung cancer
Marcel A Dammert, Johannes Brägelmann, Rachelle R Olsen, et al.
Blood
|
April 23, 2026
Expression of cFLIP in B cells is essential for diffuse large B-cell lymphoma pathogenesis
Kristie Tanavura Bariboloka, Santiago Serrano-Saenz, Deniz Pinar Savcigil, et al.
Gut
|
January 12, 2021
Placental growth factor promotes tumour desmoplasia and treatment resistance in intrahepatic cholangiocarcinoma
Shuichi Aoki, Koetsu Inoue, Sebastian Klein, et al.
Blood Cancer Discovery
|
November 8, 2022
Distinct Genetically Determined Origins of Myd88/BCL2-Driven Aggressive Lymphoma Rationalize Targeted Therapeutic Intervention Strategies
Ruth Flümann, Julia Hansen, Benedikt W Pelzer, et al.
Blood Cancer Discovery
|
January 15, 2021
An Autochthonous Mouse Model of Myd88- and BCL2-Driven Diffuse Large B-cell Lymphoma Reveals Actionable Molecular Vulnerabilities
Ruth Flümann, Tim Rehkämper, Pascal Nieper, et al.
Page
of 9